Medical Utilization in Israel During Second Intifada

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2006 by Sheba Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00350675
First received: July 9, 2006
Last updated: NA
Last verified: July 2006
History: No changes posted
  Purpose

In this ecological study we examine the impact of stress from repeated terrorist attacks during the second initifada on medical utilization by the Israeli population. We hypothesize that in weeks following serious terror attacks there will be an increase in prescriptions for psychiatric medications and an increased number of unexplained somatic complaints. We will also examine associations with overall medical utlization. We will consider age, gender and effects of geographic poximity to location of attacks.


Condition
Anxiety
Depression
Stress

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Medical Utilization, Psychotropic Prescriptions, and Somatic Complaints in Israel During the Second Intifada: An Ecological Study of the Impact of Stress.

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Study Start Date: July 2006
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Ecological study We will examine patterns of visits and prescirptions for all participants in two large health provider institutions in Israel.

Exclusion Criteria:

None - ecological study

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350675

Contacts
Contact: Joshua D Lipsitz, PhD 972-3-530-3505 ext 114 joshual@gertner.health.gov.il

Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Joshua D Lipsitz, PhD Gertner Institute, Sheba Medical Center
Study Chair: Raz Gross, MD Gertner Institute, Sheba Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00350675     History of Changes
Other Study ID Numbers: SHEBA-06-4194-RG-CTIL
Study First Received: July 9, 2006
Last Updated: July 9, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Depression
Behavioral Symptoms

ClinicalTrials.gov processed this record on October 16, 2014